{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:40:57Z","timestamp":1793378457571,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11033-021-06859-z","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T05:02:50Z","timestamp":1635397370000},"page":"205-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["\u03b12-antiplasmin positively regulates endothelial-to-mesenchymal transition and fibrosis progression in diabetic nephropathy"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-2113","authenticated-orcid":false,"given":"Yosuke","family":"Kanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-ichi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"6859_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fendo.2013.00007","volume":"4","author":"K Kanasaki","year":"2013","unstructured":"Kanasaki K, Taduri G, Koya D (2013) Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. Front Endocrinol (Lausanne) 4:7","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6859_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"V LeBleu","year":"2013","unstructured":"LeBleu V, Taduri G, O\u2019Connell J, Teng Y, Cooke V, Woda C, Sugimoto H, Kalluri R (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19:1047\u20131053","journal-title":"Nat Med"},{"key":"6859_CR3","doi-asserted-by":"publisher","first-page":"125469","DOI":"10.1155\/2013\/125469","volume":"2013","author":"S Srivastava","year":"2013","unstructured":"Srivastava S, Koya D, Kanasaki K (2013) MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT. Biomed Res Int 2013:125469","journal-title":"Biomed Res Int"},{"key":"6859_CR4","doi-asserted-by":"publisher","first-page":"E619","DOI":"10.3390\/ijms20030619","volume":"20","author":"Y Kanno","year":"2019","unstructured":"Kanno Y (2019) The role of fibrinolytic regulators in vascular dysfunction of systemic sclerosis. Int J Mol Sci 20:E619","journal-title":"Int J Mol Sci"},{"key":"6859_CR5","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.2337\/db09-1631","volume":"59","author":"J Li","year":"2010","unstructured":"Li J, Qu X, Yao J, Caruana G, Ricardo S, Yamamoto Y, Yamamoto H, Bertram J (2010) Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes 59:2612\u20132624","journal-title":"Diabetes"},{"key":"6859_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2018.06.001","volume":"833","author":"D Sanajou","year":"2018","unstructured":"Sanajou D, Ghorbani Haghjo A, Argani H, Aslani S (2018) AGE-RAGE axis blockade in diabetic nephropathy: current status and future directions. Eur J Pharmacol 833:158\u2013164","journal-title":"Eur J Pharmacol"},{"key":"6859_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1515\/bmc-2016-0021","volume":"7","author":"A Kumar Pasupulati","year":"2016","unstructured":"Kumar Pasupulati A, Chitra P, Reddy G (2016) Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy. Biomol Concepts 7:293\u2013309","journal-title":"Biomol Concepts"},{"key":"6859_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.7150\/ijbs.12690","volume":"12","author":"Y Kanno","year":"2016","unstructured":"Kanno Y, Ishisaki A, Kawashita E, Kuretake H, Ikeda K, Matsuo O (2016) uPA attenuated LPS-induced inflammatory osteoclastogenesis through the plasmin\/PAR-1\/Ca2+\/CaMKK\/AMPK axis. Int J Biol Sci 12:63\u201371","journal-title":"Int J Biol Sci"},{"key":"6859_CR9","doi-asserted-by":"publisher","first-page":"8952","DOI":"10.1074\/jbc.M110.152181","volume":"286","author":"Y Kanno","year":"2011","unstructured":"Kanno Y, Ishisaki A, Kawashita E, Chosa N, Nakajima K, Nishihara T, Toyoshima K, Okada K, Ueshima S, Matsushita K, Matsuo O, Matsuno H (2011) Plasminogen\/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. J Biol Chem 286:8952\u20138960","journal-title":"J Biol Chem"},{"key":"6859_CR10","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1172\/JCI118694","volume":"97","author":"P Menoud","year":"1996","unstructured":"Menoud P, Sappino N, Boudal-Khoshbeen M, Vassalli J, Sappino A (1996) The kidney is a major site of alpha2-antiplasmin production. J Clin Invest 97:2478\u20132484","journal-title":"J Clin Invest"},{"key":"6859_CR11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/j.1538-7836.2006.01978.x","volume":"4","author":"Y Kanno","year":"2006","unstructured":"Kanno Y, Hirade K, Ishisaki A, Nakajima K, Suga H, Into T, Matsushita K, Okada K, Matsuo O, Matsuno H (2006) Lack of alpha2-antiplasmin improves cutaneous wound healing via over-released vascular endothelial growth factor-induced angiogenesis in wound lesions. J Thromb Haemost 4:1602\u20131610","journal-title":"J Thromb Haemost"},{"key":"6859_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/iid3.302","volume":"8","author":"Y Kanno","year":"2020","unstructured":"Kanno Y, Miyashita M, Seishima M, Matsuo O (2020) \u03b12AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responses. Immun Inflamm Dis 8:267\u2013278","journal-title":"Immun Inflamm Dis"},{"key":"6859_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3892\/ijmm.2017.3055","volume":"40","author":"Y Kanno","year":"2017","unstructured":"Kanno Y, Ishisaki A, Kuretake H, Maruyama C, Matsuda A, Matsuo O (2017) alpha2-antiplasmin modulates bone formation by negatively regulating osteoblast differentiation and function. Int J Mol Med 40:854\u2013858","journal-title":"Int J Mol Med"},{"key":"6859_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2353\/ajpath.2010.090150","volume":"176","author":"Y Kanno","year":"2010","unstructured":"Kanno Y, Kawashita E, Minamida M, Kaneiwa A, Okada K, Ueshima S, Matsuo O, Matsuno H (2010) alpha2-antiplasmin is associated with the progression of fibrosis. Am J Pathol 176:238\u2013245","journal-title":"Am J Pathol"},{"key":"6859_CR15","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1038\/srep05967","volume":"4","author":"Y Kanno","year":"2014","unstructured":"Kanno Y, Kawashita E, Kokado A, Kuretake H, Ikeda K, Okada K, Seishima M, Ueshima S, Matsuo O, Matsuno H (2014) \u03b12AP mediated myofibroblast formation and the development of renal fibrosis in unilateral ureteral obstruction. Sci Rep 4:5967","journal-title":"Sci Rep"},{"key":"6859_CR16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jid.2015.12.028","volume":"136","author":"Y Kanno","year":"2016","unstructured":"Kanno Y, Shu E, Kanoh H, Seishima M (2016) The antifibrotic effect of \u03b12AP neutralization in systemic sclerosis dermal fibroblasts and mouse models of systemic sclerosis. J Invest Dermatol 136:762\u2013769","journal-title":"J Invest Dermatol"},{"key":"6859_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/art.37767","volume":"65","author":"Y Kanno","year":"2013","unstructured":"Kanno Y, Kawashita E, Kokado A, Okada K, Ueshima S, Matsuo O, Matsuno H (2013) Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F2\u03b1 synthesis through adipose triglyceride lipase\/calcium-independent phospholipase A2. Arthritis Rheum 65:492\u2013502","journal-title":"Arthritis Rheum"},{"key":"6859_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13075-017-1227-y","volume":"19","author":"Y Kanno","year":"2017","unstructured":"Kanno Y, Shu E, Kanoh H, Matsuda A, Seishima M (2017) \u03b12AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of \u03b12AP in vascular dysfunction in systemic sclerosis. Arthritis Res Ther 19:22","journal-title":"Arthritis Res Ther"},{"key":"6859_CR19","doi-asserted-by":"publisher","first-page":"317292","DOI":"10.1155\/2014\/317292","volume":"2014","author":"S Polat","year":"2014","unstructured":"Polat S, Ugurlu N, Yulek F, Simavli H, Ersoy R, Cakir B, Erel O (2014) Evaluation of serum fibrinogen, plasminogen, \u03b12-anti-plasmin, and plasminogen activator inhibitor levels (PAI) and their correlation with presence of retinopathy in patients with type 1 DM. J Diabetes Res 2014:317292","journal-title":"J Diabetes Res"},{"key":"6859_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0009-8981(00)00335-1","volume":"301","author":"Y Aso","year":"2000","unstructured":"Aso Y, Fujiwara Y, Tayama K, Takebayashi K, Inukai T, Takemura Y (2000) Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes. Clin Chim Acta 301:135\u2013145","journal-title":"Clin Chim Acta"},{"key":"6859_CR21","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1055\/s-0038-1657694","volume":"78","author":"K Okada","year":"1997","unstructured":"Okada K, Lijnen H, Dewerchin M, Belayew A, Matsuo O, Collen D, Bernaerts R (1997) Characterization and targeting of the murine alpha2-antiplasmin gene. Thromb Haemost 78:1104\u20131110","journal-title":"Thromb Haemost"},{"key":"6859_CR22","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1038\/jid.2008.157","volume":"128","author":"Y Kanno","year":"2008","unstructured":"Kanno Y, Kaneiwa A, Minamida M, Kanno M, Tomogane K, Takeuchi K, Okada K, Ueshima S, Matsuo O, Matsuno H (2008) The absence of uPAR is associated with the progression of dermal fibrosis. J Invest Dermatol 128:2792\u20132797","journal-title":"J Invest Dermatol"},{"key":"6859_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cvr\/cvm049","volume":"77","author":"Y Kanno","year":"2008","unstructured":"Kanno Y, Into T, Lowenstein C, Matsushita K (2008) Nitric oxide regulates vascular calcification by interfering with TGF-b signalling. Cardiovasc Res 77:221\u2013230","journal-title":"Cardiovasc Res"},{"key":"6859_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/iid3.116","volume":"4","author":"Y Kanno","year":"2016","unstructured":"Kanno Y, Ishisaki A, Miyashita M, Matsuo O (2016) The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin \u03b23\/Akt pathway. Immun Inflamm Dis 4:338\u2013349","journal-title":"Immun Inflamm Dis"},{"key":"6859_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/iid3.169","volume":"5","author":"Y Kanno","year":"2017","unstructured":"Kanno Y, Maruyama C, Matsuda A, Ishisaki A (2017) uPA-derived peptide, \u00c56 is involved in the suppression of lipopolysaccaride-promoted inflammatory osteoclastogenesis and the resultant bone loss. Immun Inflamm Dis 5:289\u2013299","journal-title":"Immun Inflamm Dis"},{"key":"6859_CR26","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1172\/JCI58642","volume":"122","author":"R Deane","year":"2012","unstructured":"Deane R, Singh I, Sagare AP, Bell RD, Ross NT, LaRue B, Love R, Perry S, Paquette N, Deane RJ, Thiyagarajan M, Zarcone T, Fritz G, Friedman AE, Miller BL, Zlokovic BV (2012) A multimodal RAGE-specific inhibitor reduces amyloid b-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122:1377\u20131392","journal-title":"J Clin Invest"},{"key":"6859_CR27","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.4049\/jimmunol.1601696","volume":"199","author":"J Xu","year":"2017","unstructured":"Xu J, Tao B, Guo X, Zhou S, Li Y, Zhang Y, Zhou Z, Cheng H, Zhang X, Ke Y (2017) Macrophage-restricted Shp2 tyrosine phosphatase acts as a rheostat for MMP12 through TGF-b activation in the prevention of age-related emphysema in mice. J Immunol 199:2323\u20132332","journal-title":"J Immunol"},{"key":"6859_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","volume":"16","author":"Y Han","year":"2018","unstructured":"Han Y, Xu X, Tang C, Gao P, Chen X, Xiong X (2018) Reactive oxygen species promote tubular injury in diabetic nephropathy: the role of the mitochondrial rostxnip-nlrp3 biological axis. Redox Biol 16:32\u201346","journal-title":"Redox Biol"},{"key":"6859_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1755-1536-7-12","volume":"7","author":"S Srivastava","year":"2014","unstructured":"Srivastava S, Shi S, Koya D, Kanasaki K (2014) Lipid mediators in diabetic nephropathy. Fibrogenesis Tissue Repair 7:12","journal-title":"Fibrogenesis Tissue Repair"},{"key":"6859_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/jnc.12281","volume":"126","author":"E Kawashita","year":"2013","unstructured":"Kawashita E, Kanno Y, Asayama H, Okada K, Ueshima S, Matsuo O, Matsuno H (2013) Involvement of \u03b12-antiplasmin in dendritic growth of hippocampal neurons. J Neurochem 126:58\u201369","journal-title":"J Neurochem"},{"key":"6859_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000081919","volume":"14","author":"C Erem","year":"2005","unstructured":"Erem C, Hacihasano\u011flu A, Celik S, Ovali E, Ers\u00f6z H, Ukin\u00e7 K, Deger O, Telatar M (2005) Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract 14:22\u201330","journal-title":"Med Princ Pract"},{"key":"6859_CR32","first-page":"481","volume":"58","author":"R Madan","year":"2010","unstructured":"Madan R, Gupt B, Saluja S, Kansra U, Tripathi B, Guliani B (2010) Coagulation profile in diabetes and its association with diabetic microvascular complications. J Assoc Phys India 58:481\u2013484","journal-title":"J Assoc Phys India"},{"key":"6859_CR33","first-page":"152","volume":"10","author":"M Waasdorp","year":"2017","unstructured":"Waasdorp M, Duitman J, Spek C (2017) Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner. Biochem Biophys Rep 10:152\u2013156","journal-title":"Biochem Biophys Rep"},{"key":"6859_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1124\/jpet.119.258244","volume":"371","author":"X Zhou","year":"2019","unstructured":"Zhou X, Muise E, Haimbach R, Sebhat I, Zhu Y, Liu F, Souza S, Kan Y, Pinto S, Kelley D, Hoek M (2019) PAN-AMPK activation improves renal function in a rat model of progressive diabetic nephropathy. J Pharmacol Exp Ther 371:45\u201355","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06859-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06859-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06859-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T14:26:42Z","timestamp":1641824802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06859-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6859"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06859-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The mice experiments in this study were approved by the Animal Research Committee of Doshisha Women\u2019s College of Liberal Arts (Approval ID: Y17-015), and were carried out in accordance with the rules and regulations of the institutions and the government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}